Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px
Document › Details

CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA.

Organisations Organisation CRISPR Therapeutics AG (Nasdaq: CRSP)
  Group CRISPR Therapeutics (Group)
  Organisation 2 MaSTherCell S.A. (Manufacturing Synergies for Therapeutic Cells)
  Group Orgenesis (Group)
Products Product CRISPR gene editing technology
  Product 2 CTX101 (CRISPR Therapeutics)
Persons Person Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)
  Person 2 Ho, Tony (CRISPR Therapeutics 201708– EVP + Head RnD)
     


   
Record changed: 2017-11-17

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for CRISPR Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top